LSTM Home > LSTM Research > LSTM Online Archive

Pneumonia in low and middle income countries: progress and challenges

Downloads

Downloads per month over past year

Zar, H. J., Madhi, S. A., Aston, Stephen and Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116 (2013) 'Pneumonia in low and middle income countries: progress and challenges'. Thorax, Vol 68, Issue 11, pp. 1052-1056.

[img]
Preview
Text
Zar-2013-Pneumonia_in_low_and_middle_income_co.pdf - Published Version
Available under License Creative Commons Attribution.

Download (162kB)

Abstract

Pneumonia remains the leading cause of childhood mortality and the most common reason for adult hospitalisation in low and middle income countries, despite advances in preventative and management strategies. In the last decade, pneumonia mortality in children has fallen to approximately 1.3 million cases in 2011, with most deaths occurring in low income countries. Important recent advances include more widespread implementation of protein-polysaccharide conjugate vaccines against Haemophilus influenzae type B and Streptococcus pneumoniae, implementation of case-management algorithms and better prevention and treatment of HIV. Determining the aetiology of pneumonia is challenging in the absence of reliable diagnostic tests. High uptake of new bacterial conjugate vaccines may impact on pneumonia burden, aetiology and empiric therapy but implementation in immunisation programmes in many low and middle income countries remains an obstacle. Widespread implementation of currently effective preventative and management strategies for pneumonia remains challenging in many low and middle income countries.

Item Type: Article
Additional Information: Author Affiliations 1Department of Paediatrics and Child Health, Red Cross War Memorial Childrens Hospital, University of Cape Town, Cape Town, South Africa 2National Institute for Communicable Diseases, Division of National Health Laboratory Service, Johannesburg, South Africa 3Medical Research Council: Respiratory and Meningeal Pathogens Research Unit & Department of Science/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa 4Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi 5Liverpool School of Tropical Medicine, Liverpool, UK
Uncontrolled Keywords: Pneumonia - epidemiology; Pneumonia - aetiology; Childhood pneumonia; Pneumonia - vaccines; Pneumonia - treatment
Subjects: WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 202 Pneumonia (General or not elsewhere classified)
WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 204 Pneumococcal pneumonia. Staphylococcal pneumonia
WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.5 Complications
WS Pediatrics > Diseases of Children and Adolescents > By System > WS 280 Respiratory system
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1136/thoraxjnl-2013-204247
Depositing User: Julia Martin
Date Deposited: 01 Sep 2014 11:22
Last Modified: 07 Oct 2019 08:24
URI: https://archive.lstmed.ac.uk/id/eprint/4436

Statistics

View details

Actions (login required)

Edit Item Edit Item